Table 19 |
|
Research gaps |
|
Basic science and physiological studies |
|
• Mechanisms of causation of hypertensive disorders of pregnancy and how these cause stillbirths* |
|
• Auto-immune pathophysiology in stillbirth causation |
|
• Association of periodontal disease with pre-eclampsia and pathophysiology of subsequent stillbirth* |
|
• Dynamics of stillbirth causation in intrahepatic cholestasis |
|
• Drug safety and efficacy studies: |
|
◦ Anti-malarials in pregnancy |
|
◦ Drugs for intrahepatic cholestasis |
|
◦ Non-penicillin treatments for syphilis |
|
◦ Antibiotic use in pregnancy |
|
• Identification of other unknown risk factors |
|
• Prevalence of uterine abnormalities in low-/middle-income countries |
|
Pilot/cohort studies of interventions |
|
• New approaches for PIH and chronic hypertension management in community settings* |
|
• Management protocols for HIV and syphilis co-infection |
|
• Management of penicillin drug allergy in community settings |
|
• Diagnosis and surgical repair of uterine abnormalities in women with recurrent fetal loss |
|
• Intravenous immunoglobulin treatment (compared to heparin, aspirin, or other anti-coagulants) in selected populations with recurrent pregnancy loss and antiphospholipid antibodies |
|
Well-designed large RCTs of interventions powered to detect stillbirths |
|
• Periodontal care studies powered to detect impact on stillbirth rates* |
|
• Calcium supplementation to prevent PIH and pre-eclampsia in deficient populations |
|
• Anti-oxidant supplementation in deficient populations |
|
• Management of intrahepatic cholestasis including nonstress test, amniotic fluid index, meconium screening and early delivery |
|
• Calcium supplementation in high-risk pregnancies* |
|
• Antibiotics for pPROM* |
|
Effectiveness trials in large populations/at scale |
|
• Maternal anti-helminthic treatment: impact on maternal anaemia and stillbirth* |
|
• On-site syphilis testing and treatment |
|
• ITNs for Plasmodium vivax and in lower-transmission settings (Asia and Latin America) |
|
|
|
*Priority areas |
|
Menezes et al. BMC Pregnancy and Childbirth 2009 9(Suppl 1):S4 doi:10.1186/1471-2393-9-S1-S4 |